XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jan. 28, 2023
Jul. 30, 2022
Apr. 30, 2022
Jan. 29, 2022
Jul. 31, 2021
Jan. 28, 2023
Jan. 29, 2022
Apr. 30, 2022
Statement of Cash Flows [Abstract]                
Net income (loss) $ 53,847 $ 24,260 $ 63,399 $ 56,575 $ 33,802 $ 131,756 $ 138,315  
Adjustments to reconcile net income to net cash used in operating activities:                
Depreciation           34,138 32,999  
Amortization           28,160 28,406  
Gains on investments 0     (13,092)   0 (100,919)  
Non-cash employee compensation           11,349 18,384  
Non-cash losses (gains) and other, net           7,227 5,815  
Change in assets and liabilities:                
Receivables           (729,039) (850,628)  
Inventory           (155,184) (132,689)  
Accounts payable           20,947 110,862  
Accrued liabilities           (40,909) (49,296)  
Other changes from operating activities, net           (36,642) (35,388)  
Net cash used in operating activities           (728,197) (834,139)  
Investing activities:                
Additions to property and equipment           (42,442) (26,488)  
Collection of DPP receivable           758,001 918,354  
Payments related to acquisitions, net of cash acquired           (33,257) (19,793)  
Payments related to investments           (15,000) 0  
Sale of investments           0 74,346  
Net cash provided by investing activities           667,302 946,419  
Financing activities:                
Dividends paid           (75,954) (75,746)  
Repurchases of common stock           (15,000) 0  
Payments on long-term debt           0 (100,750)  
Draw on revolving credit           146,000 82,000  
Other financing activities           12,866 4,030  
Net cash provided by (used in) financing activities           67,912 (90,466)  
Effect of exchange rate changes on cash           (1,741) (14)  
Net change in cash and cash equivalents           5,276 21,800  
Cash and cash equivalents at beginning of period   $ 142,014 165,044   $ 143,244 142,014 143,244 $ 143,244
Cash and cash equivalents at end of period $ 147,290   $ 142,014 $ 165,044   147,290 165,044 $ 142,014
Supplemental disclosure of non-cash investing activity:                
Noncash investments acquired           $ 746,321 $ 822,787